US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist
  • 4.910
  • +0.260+5.59%
Trading May 13 11:17 ET
3.45BMarket Cap12.92P/E (TTM)

Summit Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: May 7, 2024

Based on 2 analysts giving stock ratings to Summit Therapeutics in the past 3 months

Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: May 7, 2024

The average Summit Therapeutics stock price target is 7.50 with a max estimate of 8.00 and a min estimate of 7.00

Review Summit Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: May 7, 2024

Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: May 7, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg